Replies to post #159909 on Biotech Values

[DewDiligence]

How far would that go in satisfying Myriad?

The devil is in the details; however, it’s reasonable (IMO) to surmise that MYGN has probably averted the worst-case scenario of having its IP rendered valueless. The stock was up ~2% today on a day when the S&P 500 was sharply down.